<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05017207</url>
  </required_header>
  <id_info>
    <org_study_id>Trquoc</org_study_id>
    <nct_id>NCT05017207</nct_id>
  </id_info>
  <brief_title>Pancreatic Fistula After Pancreaticoduodenectomy in Treatment Periampullary Cancer and Risk Factors: A Multicenter Study</brief_title>
  <official_title>Complication of Pancreatic Fistula After Pancreaticoduodenectomy in Treatment Periampullary Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vo Truong Quoc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Medicine and Pharmacy at Ho Chi Minh City</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who are diagnosed with periampullary cancer will be performed&#xD;
      pancreaticoduodenectomy with 3 types of pancreatic-jejunal anastomosis reconstructions. The&#xD;
      investigator will analysis the complication of pancreatic fistula about: the clinical&#xD;
      symptoms, laboratory test changing, intra-operative morphology, the risk factors&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will conduct at two centers at the same time: University of Medicine and Pharmacy&#xD;
      Center and Cho Ray Hospital. The patients will be consulted to participate to this research&#xD;
      from September, 2021 to April, 2023.&#xD;
&#xD;
      Plan for conducting study:&#xD;
&#xD;
        -  The investigator consults and gets consensus form of the patient with periampullary&#xD;
           cancer.&#xD;
&#xD;
        -  The patient will be prepared for pancreaticoduodenectomy: pre-operative laboratory test,&#xD;
           pre-operative biliary drainage, anesthetic checking.&#xD;
&#xD;
        -  The investigator collected intr-operative data, include type of pancreatic-duodenal&#xD;
           reconstruction, type of pancreatic duct's drainage, quantity of blood loss and blood&#xD;
           transfusion.&#xD;
&#xD;
        -  The investor follows post-operative period.&#xD;
&#xD;
        -  If there are pancreatic fistula appear, the investigator will collect the clinical&#xD;
           signs, laboratory test changing, re-operative morphology.&#xD;
&#xD;
        -  The investigator analysis the risk factors of pancreatic fistula.&#xD;
&#xD;
      Data analysis:&#xD;
&#xD;
        -  To determine the incidence of pancreatic fistula, the morphology of pancreatic fistula,&#xD;
           descriptive statistics will be used.&#xD;
&#xD;
        -  To determine the risk factors of pancreatic fistula, logistic regression will be used.&#xD;
&#xD;
      Sample size:&#xD;
&#xD;
        -  The investigator plans to collect 145 patients in the research period.&#xD;
&#xD;
      Plan for missing data:&#xD;
&#xD;
        -  Any case that miss information will be removed from the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Pancreatic fistula</measure>
    <time_frame>30 days of post-operative period</time_frame>
    <description>The investigator will describe the day that appears pancreatic fistula, the clinical symptoms, intra-operative morphology if being indicated to re-operate. The measurement tool to diagnose pancreatic fistula is fluid amylase on the POD3 (fluid amylse is 3 times compared to serum's amylase)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors relate to pancreatic fistula</measure>
    <time_frame>30 days of post-operative period</time_frame>
    <description>The investigator will analyse some of the risk factors that relate to pancreatic fistula, including pre-operative factors (BMI, albumin, bilirubin, biliary drainage), intra-operative elements (pancreatic duct 's diameter, pancreatic textile, blood transfusion, portal vein reconstruction), and post-operative factors (abdominal drainage's volume, fluid amylase, abdominal abscess..). The investigator will use the multivariable regression model to determine the risk factors (p-value&lt;0.05)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short-term result in treatment of post-operative pancreatic fistula</measure>
    <time_frame>30 days of post-operatvive period</time_frame>
    <description>The investigator will describe the result of pancreatic fistula treatment: intra-operative morphology, re-operative success ratio, morbidities.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Pancreatic Fistula</condition>
  <arm_group>
    <arm_group_label>Patient with periampullary cancer and pancreaticoduodenectomy</arm_group_label>
    <description>Only one group of patient with periampullary cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreaticoduodenectomy</intervention_name>
    <description>Pancreaticoduodenectomy with one of 3 type of pancreatic-duodenal reconstructions</description>
    <arm_group_label>Patient with periampullary cancer and pancreaticoduodenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Periampullary cancer with postoperative pathology is adenocarcinoma&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with periampullary cancer and can be performed pancreaticoduodenectomy.&#xD;
&#xD;
          -  Pancreaticoduodenectomy with one of three types of pancreatic - duodenal anastomosis&#xD;
             reconstructions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient does not consent to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Truong Quoc Vo</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Medicine and Pharmacy at HoChiMinh City</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Truong Quoc Vo, Doctor</last_name>
    <phone>084364662378</phone>
    <email>bsvotruongquoc@ump.edu.vn</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center of HCMC</name>
      <address>
        <city>Ho Chi Minh City</city>
        <zip>700000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Quoc Tr Vo, Doctor</last_name>
      <phone>84364662378</phone>
      <email>bsvotruongquoc@ump.edu.vn</email>
    </contact>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <link>
    <url>http://pubmed.ncbi.nlm.nih.gov/31391768/</url>
    <description>Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery</description>
  </link>
  <reference>
    <citation>Kawaida H, Kono H, Hosomura N, Amemiya H, Itakura J, Fujii H, Ichikawa D. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J Gastroenterol. 2019 Jul 28;25(28):3722-3737. doi: 10.3748/wjg.v25.i28.3722. Review.</citation>
    <PMID>31391768</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Medicine and Pharmacy at Ho Chi Minh City</investigator_affiliation>
    <investigator_full_name>Vo Truong Quoc</investigator_full_name>
    <investigator_title>Doctor, Lecturer, Surgeon</investigator_title>
  </responsible_party>
  <keyword>Risk factor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The IDP will be saved as excel and spss file</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

